comparemela.com

Latest Breaking News On - Fuchs daily - Page 2 : comparemela.com

Fuchs (OTCMKTS:FUPBY) Sets New 12-Month High at $12 68

Fuchs SE (OTCMKTS:FUPBY – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The stock traded as high as $12.68 and last traded at $12.37, with a volume of 9655 shares trading hands. The stock had previously closed at $12.34. Fuchs Price Performance The firm has a market cap […]

Avivagen (OTCMKTS:VIVXF) & Fuchs (OTCMKTS:FUPBY) Critical Analysis

Fuchs (OTCMKTS:FUPBY – Get Free Report) and Avivagen (OTCMKTS:VIVXF – Get Free Report) are both oils/energy companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Valuation & Earnings This table compares Fuchs and Avivagen’s top-line […]

Fuchs (FRA:FPE) Shares Down 1 4%

Fuchs SE (FRA:FPE – Get Free Report)’s stock price traded down 1.4% during trading on Tuesday . The company traded as low as €32.60 ($35.43) and last traded at €32.75 ($35.60). 33,761 shares were traded during mid-day trading, The stock had previously closed at €33.20 ($36.09). Fuchs Stock Performance The business has a 50 day […]

Fuchs (OTCMKTS:FUPBY) Trading 0 3% Higher

Shares of Fuchs SE (OTCMKTS:FUPBY – Get Free Report) shot up 0.3% during trading on Thursday . The company traded as high as $11.03 and last traded at $11.00. 2,572 shares were traded during trading, a decline of 33% from the average session volume of 3,831 shares. The stock had previously closed at $10.97. Fuchs […]

Fuchs (OTCMKTS:FUPBY) Trading Up 0 3%

Shares of Fuchs SE (OTCMKTS:FUPBY – Get Free Report) were up 0.3% during mid-day trading on Thursday . The stock traded as high as $11.03 and last traded at $11.00. Approximately 2,572 shares traded hands during trading, a decline of 33% from the average daily volume of 3,831 shares. The stock had previously closed at […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.